on SCOR (EPA:SCR)
SCOR validates its retrocession agreements with Covéa
On June 25, 2026, SCOR received confirmation from the arbitration tribunal on the validity of the retrocession agreements concluded with Covéa in June 2021. These agreements allow the transfer of 30% of SCOR's Life & Health portfolio to Covéa, based on the assets held as of December 31, 2020.
The court not only validated these agreements but also ruled that Covéa must be compensated with $488.3 million. After provisions, SCOR estimates that the impact on its second-quarter 2026 results will be approximately €50 million, while maintaining its solvency ratio and liquidity.
SCOR is focused on completing its Forward 2026 plan, with an emphasis on balance sheet resilience and underwriting discipline.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SCOR news